💨 Abstract

Adma Biologics Inc. reported a first-quarter net income of $26.9 million, with adjusted earnings of 14 cents per share and revenue of $114.8 million. The company's shares have increased by 38% year-to-date, reaching $23.61 in Wednesday's trading, having more than tripled in the past 12 months. The news was generated by Automated Insights using data from Zacks Investment Research.

Courtesy: wtop.com

Summarized by Einstein Beta 🤖